Is MDGL stock safe? | Glauxie AI

Q: Is MDGL stock safe?

Madrigal Pharmaceuticals, Inc. (MDGL) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO William J. Sibold. Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic,... Employees: 915.

Q: What are the risks of investing in MDGL?

Identify key risks of investing in MDGL — debt, competition, volatility, and sector headwinds.

Q: Is MDGL a good long-term investment?

Evaluate MDGL as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does MDGL have?

Review MDGL total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is MDGL stock safe?

🦉

Madrigal Pharmaceuticals, Inc. (MDGL)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOWilliam J. Sibold

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid...

Key Executives

Name	Title
Carole Huntsman	Executive Vice President & Chief Commercial Officer
Clint Wallace	Executive Vice President & Chief Human Resources Officer
David Soergel	Executive VP & Chief Medical Officer
Mardi C. Dier	Executive Vice President & Chief Financial Officer
Mark Underwood	Executive Vice President of Business Planning & Operations
Rebecca A. Taub	Founder, Senior Scientific & Medical Advisor and Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

MDGL Profile Financials

What are the risks of investing in MDGL? Is MDGL a good long-term investment? How much debt does MDGL have?